OR7E18P

Across TCGA pan-cancer cohorts, OR7E18P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated OR7E18P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher OR7E18P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR7E18P expression acts as an unfavorable survival marker.

MESO, UCEC, and PAAD are the cancer types where OR7E18P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	II,III,IV	0.166	0.584	<.001	54	view →
UCEC	DFS	Tertile	All	0.747	0.901	.002	48	view →
PAAD	DFS	Tertile	II,III,IV	0.184	0.455	.004	45	view →
LUAD	OS	Tertile	II,III,IV	0.243	0.713	<.001	36	view →
KIRP	DFS	Tertile	II,III,IV	0.038	0.771	<.001	36	view →
LGG	DFS	Tertile	All	0.386	0.746	<.001	36	view →
COAD	DFS	Tertile	III,IV	0.212	0.535	.013	24	view →
BRCA	OS	Tertile	III,IV	0.556	0.837	.013	18	view →
PRAD	OS	Tertile	All	0.933	0.996	.008	12	view →
SARC	DFS	Tertile	All	0.141	0.543	.012	9	view →
LUSC	OS	Tertile	All	0.196	0.514	.028	6	view →
KIRC	OS	Tertile	All	0.715	0.820	.031	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

OR7E18P–MESO (OS)

Open the MESO breakdown →